These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120. Schön A; Madani N; Klein JC; Hubicki A; Ng D; Yang X; Smith AB; Sodroski J; Freire E Biochemistry; 2006 Sep; 45(36):10973-80. PubMed ID: 16953583 [TBL] [Abstract][Full Text] [Related]
5. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells. Mori T; Boyd MR Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340 [TBL] [Abstract][Full Text] [Related]
6. Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV. Neurath AR; Jiang S; Strick N; Lin K; Li YY; Debnath AK Nat Med; 1996 Feb; 2(2):230-4. PubMed ID: 8574970 [TBL] [Abstract][Full Text] [Related]
7. Glycodelins: role in regulation of reproduction, potential for contraceptive development and diagnosis of male infertility. Seppälä M; Koistinen H; Koistinen R; Mandelin E; Oehninger S; Clark GF; Dell A; Morris HR Hum Reprod; 1998 Jun; 13 Suppl 3():262-9l; discussion 270. PubMed ID: 9755428 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of the immunomodulatory activity of glycodelin. Karande AA; Mukhopadhyay D; Jayachandran R; Sundarraj S; Alok A Indian J Physiol Pharmacol; 2005; 49(3):271-83. PubMed ID: 16440844 [TBL] [Abstract][Full Text] [Related]
9. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation. Kalyanaraman VS; Rausch DM; Osborne J; Padgett M; Hwang KM; Lifson JD; Eiden LE J Immunol; 1990 Dec; 145(12):4072-8. PubMed ID: 1701782 [TBL] [Abstract][Full Text] [Related]
10. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703 [TBL] [Abstract][Full Text] [Related]
11. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions. Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033 [TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of negatively charged milk proteins with anti-HIV activity. Berkhout B; Derksen GC; Back NK; Klaver B; de Kruif CG; Visser S AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1101-7. PubMed ID: 9282815 [TBL] [Abstract][Full Text] [Related]
13. Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate. Martín-García J; Cocklin S; Chaiken IM; González-Scarano F J Virol; 2005 Jun; 79(11):6703-13. PubMed ID: 15890908 [TBL] [Abstract][Full Text] [Related]
14. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4. Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234 [TBL] [Abstract][Full Text] [Related]
15. Advances in uterine protein research: reproduction and cancer. Seppälä M Int J Gynaecol Obstet; 2004 May; 85(2):105-18. PubMed ID: 15099771 [TBL] [Abstract][Full Text] [Related]
16. Anti-HIV activity of a glycoprotein from first trimester placental tissue. Kondapi AK; Hafiz MA; Sivaram T Antiviral Res; 2002 Apr; 54(1):47-57. PubMed ID: 11888657 [TBL] [Abstract][Full Text] [Related]
17. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors. Chersi A; Pugliese O; Federico A; Viora M Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301 [TBL] [Abstract][Full Text] [Related]
18. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions. Caporuscio F; Tafi A; González E; Manetti F; Esté JA; Botta M Bioorg Med Chem Lett; 2009 Nov; 19(21):6087-91. PubMed ID: 19783140 [TBL] [Abstract][Full Text] [Related]
19. Viewing AIDS from a glycobiological perspective: potential linkages to the human fetoembryonic defence system hypothesis. Clark GF; Dell A; Morris HR; Patankar M; Oehninger S; Seppälä M Mol Hum Reprod; 1997 Jan; 3(1):5-13. PubMed ID: 9239703 [TBL] [Abstract][Full Text] [Related]
20. Gender-specific glycosylation of human glycodelin affects its contraceptive activity. Morris HR; Dell A; Easton RL; Panico M; Koistinen H; Koistinen R; Oehninger S; Patankar MS; Seppala M; Clark GF J Biol Chem; 1996 Dec; 271(50):32159-67. PubMed ID: 8943270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]